These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35797940)

  • 21. Results of a European-Wide External Quality Assessment (EQA) Scheme for Serological Detection of Anti-SARS-CoV-2 (CoVimm)-Pitfalls of Routine Application.
    Kittel M; Eichner R; Aida S; Bode A; Ast V; Kessler A; Neumaier M; Wölfel R; Haselmann V
    Viruses; 2022 Jul; 14(8):. PubMed ID: 36016287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
    Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y
    J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of 2 Rapid Antigen Tests During 3 Phases of SARS-CoV-2 Variants.
    Drain PK; Bemer M; Morton JF; Dalmat R; Abdille H; Thomas KK; Uppal TK; Hau D; Green HR; Gates-Hollingsworth MA; AuCoin DP; Verma SC
    JAMA Netw Open; 2022 Aug; 5(8):e2228143. PubMed ID: 36001317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy comparison of three rapid antigen tests for SARS-CoV-2 and how viral load impact their performance.
    Blairon L; Cupaiolo R; Thomas I; Piteüs S; Wilmet A; Beukinga I; Tré-Hardy M
    J Med Virol; 2021 Oct; 93(10):5783-5788. PubMed ID: 34050945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community.
    Stohr JJJM; Zwart VF; Goderski G; Meijer A; Nagel-Imming CRS; Kluytmans-van den Bergh MFQ; Pas SD; van den Oetelaar F; Hellwich M; Gan KH; Rietveld A; Verweij JJ; Murk JL; van den Bijllaardt W; Kluytmans JAJW
    Clin Microbiol Infect; 2022 May; 28(5):695-700. PubMed ID: 34363945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point of care molecular and antigen detection tests for COVID-19: current status and future prospects.
    Stokes W; Berenger BM; Venner AA; Deslandes V; Shaw JLV
    Expert Rev Mol Diagn; 2022 Aug; 22(8):797-809. PubMed ID: 36093682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serological diagnostic for SARS-CoV-2: an experimental External Quality Assessment Scheme.
    Sciacovelli L; Padoan A; Secchiero S; Plebani M
    Clin Chem Lab Med; 2021 Oct; 59(11):1878-1884. PubMed ID: 34348424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring the quality of SARS-CoV-2 virus detection in molecular diagnostic laboratories in the Eastern Mediterranean Region during the COVID-19 pandemic.
    Meredith LW; Aboualy M; Ochola R; Ozel M; Abubakar A; Barakat A
    Influenza Other Respir Viruses; 2023 Nov; 17(11):e13217. PubMed ID: 38019698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status of the lateral flow immunoassay for the detection of SARS-CoV-2 in nasopharyngeal swabs.
    Somborac Bačura A; Dorotić M; Grošić L; Džimbeg M; Dodig S
    Biochem Med (Zagreb); 2021 Jun; 31(2):020601. PubMed ID: 34140830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 rapid antigen test: High sensitivity to detect infectious virus.
    Nordgren J; Sharma S; Olsson H; Jämtberg M; Falkeborn T; Svensson L; Hagbom M
    J Clin Virol; 2021 Jul; 140():104846. PubMed ID: 33971580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OraSure InteliSwab
    Weishampel ZA; Young J; Fischl M; Fischer RJ; Donkor IO; Riopelle JC; Schulz JE; Port JR; Saturday TA; van Doremalen N; Berry JD; Munster VJ; Yinda CK
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Performance of Three Commercial SARS-CoV-2 Rapid Antigen Tests for Community-Dwelling Individuals in a Tropical Setting.
    Morales-Jadán D; Viteri-Dávila C; Castro-Rodriguez B; Vallejo-Janeta AP; Rivera-Olivero IA; Perez F; Garcia-Bereguiain MA
    Front Cell Infect Microbiol; 2022; 12():832235. PubMed ID: 35865818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic performance of molecular and serological tests of SARS-CoV-2 on well-characterised specimens from COVID-19 individuals: The EDCTP "PERFECT-study" protocol (RIA2020EF-3000).
    Fokam J; Alteri C; Colagrossi L; Genevieve AM; Takou D; Ndjolo A; Colizzi V; Ndembi N; Perno CF
    PLoS One; 2022; 17(9):e0273818. PubMed ID: 36129931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Performance Assessment of Saliva RT-PCR and Nasopharyngeal Antigen for the Detection of SARS-CoV-2 in Peru.
    Calderón RI; Jhaveri TA; Tovar MA; Palomino JS; Barreda NN; Sanabria OM; Peinado J; Ramirez C; Llanos Zavalaga LF; Valderrama G; Franke MF; Mitnick CD; Lecca L; Velásquez GE
    Microbiol Spectr; 2022 Aug; 10(4):e0086122. PubMed ID: 35867471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Screening Using Reverse Transcriptase-Quantitative Polymerase Chain Reaction or CRISPR-Based Assays in Asymptomatic College Students.
    Rauch JN; Valois E; Ponce-Rojas JC; Aralis Z; Lach RS; Zappa F; Audouard M; Solley SC; Vaidya C; Costello M; Smith H; Javanbakht A; Malear B; Polito L; Comer S; Arn K; Kosik KS; Acosta-Alvear D; Wilson MZ; Fitzgibbons L; Arias C
    JAMA Netw Open; 2021 Feb; 4(2):e2037129. PubMed ID: 33570576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid Quantitative Point-Of-Care Diagnostic Test for Post COVID-19 Vaccination Antibody Monitoring.
    Moeller ME; Engsig FN; Bade M; Fock J; Pah P; Soerensen AL; Bang D; Donolato M; Benfield T
    Microbiol Spectr; 2022 Apr; 10(2):e0039622. PubMed ID: 35357223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A localized small-scale external quality assessment (EQA) for PCR testing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the molecular laboratories.
    Li RH; Wang QY
    J Virol Methods; 2022 Mar; 301():114441. PubMed ID: 34954305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. External Quality Assessment for Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detection in Chongqing, China.
    Guo Y; Li T; Liu S; Wang K; Zhang Y; Wang L; Liao P
    Clin Lab; 2022 Jan; 68(1):. PubMed ID: 35023672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methods to evaluate the impact of SARS-CoV-2 nucleocapsid mutations on antigen detection by rapid diagnostic tests.
    Tieman BC; Kovacs S; Rodgers MA; Mohaimani A; Gregory S; Christensen D; Moore JA; Schurig-Briccio L; Hartnett J; Kar A; Leeman A; Palmer A; Rogers L; Dragoo B; Muszynski S; Noblesmith D; Gardner S; Snipe-Bushey A; Kill A; Luo X; Cherukuri S; Rae T; Marohnic CC; Cloherty GA; Muerhoff AS; Hemken PM
    Biotechniques; 2022 Sep; 73(3):136-141. PubMed ID: 36004516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.